Literature DB >> 16990582

Derivation of human embryonic stem cells from developing and arrested embryos.

Xin Zhang1, Petra Stojkovic, Stefan Przyborski, Michael Cooke, Lyle Armstrong, Majlinda Lako, Miodrag Stojkovic.   

Abstract

Human embryonic stem cells (hESC) hold huge promise in modern regenerative medicine, drug discovery, and as a model for studying early human development. However, usage of embryos and derivation of hESC for research and potential medical application has resulted in polarized ethical debates since the process involves destruction of viable developing human embryos. Here we describe that not only developing embryos (morulae and blastocysts) of both good and poor quality but also arrested embryos could be used for the derivation of hESC. Analysis of arrested embryos demonstrated that these embryos express pluripotency marker genes such OCT4, NANOG, and REX1. Derived hESC lines also expressed specific pluripotency markers (TRA-1-60, TRA-1-81, SSEA4, alkaline phosphatase, OCT4, NANOG, TERT, and REX1) and differentiated under in vitro and in vivo conditions into derivates of all three germ layers. All of the new lines, including lines derived from late arrested embryos, have normal karyotypes. These results demonstrate that arrested embryos are additional valuable resources to surplus and donated developing embryos and should be used to study early human development or derive pluripotent hESC.

Entities:  

Mesh:

Year:  2006        PMID: 16990582     DOI: 10.1634/stemcells.2006-0377

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  50 in total

1.  Vitrified blastocysts from Preimplantation Genetic Diagnosis (PGD) as a source for human Embryonic Stem Cell (hESC) derivation.

Authors:  Begoña Aran; Miquel Sole; Ignasi Rodriguez-Pizà; Mònica Parriego; Yolanda Muñoz; Montserrat Boada; Pere N Barri; Juan Carlos Izpisúa; Anna Veiga
Journal:  J Assist Reprod Genet       Date:  2012-06-27       Impact factor: 3.412

2.  Derivation and propagation of human embryonic stem cell lines from frozen embryos in an animal product-free environment.

Authors:  Emma Stephenson; Laureen Jacquet; Cristian Miere; Victoria Wood; Neli Kadeva; Glenda Cornwell; Stefano Codognotto; Yaser Dajani; Peter Braude; Dusko Ilic
Journal:  Nat Protoc       Date:  2012-06-21       Impact factor: 13.491

Review 3.  Non-embryo-destructive Extraction of Pluripotent Embryonic Stem Cells: Implications for Regenerative Medicine and Reproductive Medicine.

Authors:  R Dittrich; M W Beckmann; W Würfel
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-12       Impact factor: 2.915

4.  Derivation, characterization and differentiation of a new human embryonic stem cell line from a Chinese hatched blastocyst assisted by a non-contact laser system.

Authors:  Rongrong Wu; Chenming Xu; Fan Jin; Zhou Tan; Bin Gu; Liangbiao Chen; Xing Yao; Ming Zhang
Journal:  Hum Cell       Date:  2010-10-01       Impact factor: 4.174

Review 5.  Parthenotes as a source of embryonic stem cells.

Authors:  T A L Brevini; F Gandolfi
Journal:  Cell Prolif       Date:  2008-02       Impact factor: 6.831

Review 6.  Alternative sources of pluripotent stem cells: altered nuclear transfer.

Authors:  M L Condic
Journal:  Cell Prolif       Date:  2008-02       Impact factor: 6.831

7.  Derivation of human embryonic stem cell lines from single blastomeres of low-quality embryos by direct plating.

Authors:  Gang Yang; Qingyun Mai; Tao Li; Canquan Zhou
Journal:  J Assist Reprod Genet       Date:  2013-07-09       Impact factor: 3.412

Review 8.  Science and ethics: bridge to the future for regenerative medicine.

Authors:  Ventura-Juncá Patricio
Journal:  Int J Stem Cells       Date:  2011-11       Impact factor: 2.500

9.  Diploid, but not haploid, human embryonic stem cells can be derived from microsurgically repaired tripronuclear human zygotes.

Authors:  Yong Fan; Rong Li; Jin Huang; Yang Yu; Jie Qiao
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

Review 10.  Sources of stem cells for regenerative medicine.

Authors:  Jennifer Hipp; Anthony Atala
Journal:  Stem Cell Rev       Date:  2008       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.